IL91602A0 - Nitrate esters and pharmaceutical compositions containing them - Google Patents

Nitrate esters and pharmaceutical compositions containing them

Info

Publication number
IL91602A0
IL91602A0 IL91602A IL9160289A IL91602A0 IL 91602 A0 IL91602 A0 IL 91602A0 IL 91602 A IL91602 A IL 91602A IL 9160289 A IL9160289 A IL 9160289A IL 91602 A0 IL91602 A0 IL 91602A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
nitrate esters
nitrate
esters
Prior art date
Application number
IL91602A
Other languages
English (en)
Original Assignee
Cedona Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cedona Pharm Bv filed Critical Cedona Pharm Bv
Publication of IL91602A0 publication Critical patent/IL91602A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C203/00Esters of nitric or nitrous acid
    • C07C203/02Esters of nitric acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C203/00Esters of nitric or nitrous acid
    • C07C203/02Esters of nitric acid
    • C07C203/04Esters of nitric acid having nitrate groups bound to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C203/00Esters of nitric or nitrous acid
    • C07C203/02Esters of nitric acid
    • C07C203/08Esters of nitric acid having nitrate groups bound to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/39Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups
    • C07C205/42Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups having nitro groups or esterified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/10Dibenzothiopyrans; Hydrogenated dibenzothiopyrans
    • C07D335/12Thioxanthenes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14All rings being cycloaliphatic
    • C07C2602/26All rings being cycloaliphatic the ring system containing ten carbon atoms
    • C07C2602/28Hydrogenated naphthalenes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/30Ortho- or ortho- and peri-condensed systems containing three rings containing seven-membered rings
    • C07C2603/32Dibenzocycloheptenes; Hydrogenated dibenzocycloheptenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Indole Compounds (AREA)
  • Quinoline Compounds (AREA)
IL91602A 1988-09-15 1989-09-11 Nitrate esters and pharmaceutical compositions containing them IL91602A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8802276A NL8802276A (nl) 1988-09-15 1988-09-15 Geneesmiddel met relaxerende werking, dat als aktieve stof een nitraatester bevat.

Publications (1)

Publication Number Publication Date
IL91602A0 true IL91602A0 (en) 1990-04-29

Family

ID=19852906

Family Applications (1)

Application Number Title Priority Date Filing Date
IL91602A IL91602A0 (en) 1988-09-15 1989-09-11 Nitrate esters and pharmaceutical compositions containing them

Country Status (13)

Country Link
US (1) US5049694A (da)
EP (1) EP0359335A3 (da)
JP (1) JPH02134316A (da)
KR (1) KR900004331A (da)
AU (1) AU638413B2 (da)
DK (1) DK453089A (da)
FI (1) FI894349A7 (da)
IL (1) IL91602A0 (da)
NL (1) NL8802276A (da)
NO (1) NO171904C (da)
NZ (1) NZ230631A (da)
PT (1) PT91701B (da)
ZA (1) ZA896982B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1243367B (it) * 1990-07-26 1994-06-10 Italfarmaco Spa Derivati acidi benzoici sostituiti ad attivita' cardiovascolare
NL9001955A (nl) * 1990-09-05 1992-04-01 Cedona Pharm Bv Nieuwe thiazolidinederivaten.
JP3454531B2 (ja) * 1991-11-07 2003-10-06 三共株式会社 ニトロキシアルキルアミド誘導体
US5646181A (en) * 1992-07-02 1997-07-08 Research Foundation Of State University Of New York Method and compositions for treating impotence
IT1256450B (it) * 1992-11-26 1995-12-05 Soldato Piero Del Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione
CA2158368A1 (en) * 1993-03-15 1994-09-29 Jan Bron Use of substituted alkyl nitrates for the treatment of pathologically raised intraocular pressure
ES2065291B1 (es) * 1993-07-30 1995-10-01 Prodesfarma Sa "nitrato esteres de 1-ariloxi-3-alquilamino-2-propanoles, utilizacion y composicion farmaceutica correspondiente"
DK0722434T3 (da) * 1993-10-06 1998-11-16 Nicox Sa Salpetersyreestere, der har anti-inflammatorisk og/eller analgetisk aktivitet og fremgangsmåder til deres fremstilling
JPH09507672A (ja) * 1994-01-19 1997-08-05 ビイク ネダーラント ベスローテン フェンノートシャップ ニトロキシ基含有ベンジルアミン誘導体及び循環器疾患並びに眼内圧増加の治療のためのその使用
US5925658A (en) * 1995-03-02 1999-07-20 Sankyo Company, Limited Optically active thiazolidinone derivative
US5807847A (en) * 1996-06-04 1998-09-15 Queen's University At Kingston Nitrate esters
US20050137191A1 (en) * 1996-06-04 2005-06-23 Thatcher Gregory R. Nitrate esters and their use for mitigating cellular damage
US6310052B1 (en) 1996-06-04 2001-10-30 Queen's University At Kingston Nitrate esters and their use for neurological conditions
US7115661B1 (en) 1999-12-29 2006-10-03 Queen's University At Kingston Methods and compositions for mitigating pain
IL120531A (en) * 1997-03-26 2006-12-31 Yissum Res Dev Co Nitric oxide donors and pharmaceutical compositions containing them
RU2125040C1 (ru) * 1997-04-23 1999-01-20 Институт химической физики в Черноголовке РАН Производные янтарной кислоты, способ их получения, промежуточные соединения для их синтеза и способ получения промежуточных соединений
RU2146243C1 (ru) * 1998-04-22 2000-03-10 Институт химической физики в Черноголовке РАН Нитраты спиртов, содержащие амидную, динитрометиленовую и нитроаминную группы, способ их получения, 3-(ациламинодинитроалкил)-тетрагидро-1,3-оксазолы и - оксазины, способ их получения
US6056966A (en) * 1998-05-18 2000-05-02 Baker Norton Pharmaceuticals, Inc. Method and compositions for treating impotence
AU2003265769A1 (en) * 2002-05-02 2003-11-17 Ciphergen Biosystems, Inc. Biochips with surfaces coated with polysaccharide based hydrogels
JP4891982B2 (ja) * 2008-12-15 2012-03-07 スガツネ工業株式会社 2軸ヒンジ装置及び携帯機器
WO2013060673A1 (en) * 2011-10-24 2013-05-02 Nicox S.A. Quinone based nitric oxide donating compounds

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2139364A (en) * 1937-03-22 1938-12-06 Shell Dev Alpha-substituted glycerol nitrates
NL49919C (da) * 1938-02-10
US2294849A (en) * 1938-08-20 1942-09-01 Sharples Chemicals Inc Manufacture of nitric acid esters
US2549687A (en) * 1947-11-21 1951-04-17 Duriron Co Heat exchanger
GB713329A (en) * 1951-01-08 1954-08-11 Nat Res Dev Improvements in or relating to production of nitric acid esters of higher alcohols and glycols
US2683164A (en) * 1951-12-21 1954-07-06 Trojan Powder Co Preparation of 1, 2, 6-hexanetriol trinitrate
US2742492A (en) * 1954-07-29 1956-04-17 Ethyl Corp Nitrate formulations
NL98269C (da) * 1956-02-24
NL110701C (da) * 1960-03-14
US3428667A (en) * 1962-09-20 1969-02-18 Aerojet General Co N,n-dinitramines of certain organic compounds and process
US3419571A (en) * 1966-04-06 1968-12-31 Warner Lambert Pharmaceutical Method for relieving coronary insufficiency
US3409620A (en) * 1967-02-06 1968-11-05 Mario Biazzi Sa Dr Ing Continuous manufacture in vacuum of nitric esters and/or organic nitro compounds
US3470231A (en) * 1967-05-29 1969-09-30 Us Navy Method of stabilizing nitric acid esters
US3853891A (en) * 1971-06-16 1974-12-10 Sandoz Ag N-(n-(cyanoalkyl)-n-nitroso)amino-aminoalcohol
US4336408A (en) * 1977-11-25 1982-06-22 Thiokol Corporation 2-Hydroxymethyl-1,3-propanediol preparation
JPS56113748A (en) * 1980-02-13 1981-09-07 Kowa Co Aminoethanol derivative and its preparation
US4417903A (en) * 1982-10-15 1983-11-29 Ethyl Corporation Diesel fuel composition
DE3305690A1 (de) * 1983-02-18 1984-08-30 Heinrich Mack Nachf., 7918 Illertissen Glycerinmononitrate zur behandlung der angina pectoris
US4479905A (en) * 1983-09-19 1984-10-30 Ethyl Corporation Nitration process
DE3443998A1 (de) * 1984-12-01 1986-06-05 Boehringer Mannheim Gmbh, 6800 Mannheim Amino-propanol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
DE3512627A1 (de) * 1985-04-06 1986-10-09 Boehringer Mannheim Gmbh, 6800 Mannheim Amino-propanol-derivate, verfahren zu deren herstellung, verwendung derselben und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
FI894349L (fi) 1990-03-16
DK453089D0 (da) 1989-09-14
EP0359335A3 (en) 1991-03-06
NL8802276A (nl) 1990-04-02
PT91701B (pt) 1995-06-30
NZ230631A (en) 1993-01-27
AU638413B2 (en) 1993-07-01
DK453089A (da) 1990-03-16
PT91701A (pt) 1990-03-30
US5049694A (en) 1991-09-17
NO893686D0 (no) 1989-09-14
JPH02134316A (ja) 1990-05-23
EP0359335A2 (en) 1990-03-21
KR900004331A (ko) 1990-04-12
NO893686L (no) 1990-03-16
FI894349A7 (fi) 1990-03-16
ZA896982B (en) 1990-06-27
FI894349A0 (fi) 1989-09-14
NO171904C (no) 1993-05-19
NO171904B (no) 1993-02-08
AU4133089A (en) 1990-03-22

Similar Documents

Publication Publication Date Title
IL90067A0 (en) 1alpha-hydroxyvitamin-d compounds and pharmaceutical compositions containing them
IL88988A0 (en) Didehydro-vitamin d3 derivatives and pharmaceutical compositions containing them
IL89904A0 (en) Vitamin d analogues and pharmaceutical compositions containing them
IL95351A0 (en) 17beta-acyl-4-aza-5alpha-androst-1-en-3-ones and pharmaceutical compositions containing them
IL91602A0 (en) Nitrate esters and pharmaceutical compositions containing them
IL105218A0 (en) Hexanones and pharmaceutical compositions containing them
IL105223A0 (en) Cyclohexane-ylidenes and pharmaceutical compositions containing them
IL82221A0 (en) Phenyl-piperazines and pharmaceutical compositions containing them
IL86502A0 (en) Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives and pharmaceutical compositions containing them
GB2207922B (en) Tripeptides and pharmaceutical compositions containing them
NZ226002A (en) Peptidylheterocyclic compounds and pharmaceutical compositions
NZ226450A (en) Crystalline-1-carbacephalosporin and pharmaceutical compositions
IL106098A0 (en) Heteroarylnaphthalenes and pharmaceutical compositions containing them
IL88989A0 (en) 16-dehydro-vitamin d3 derivatives their preparation and pharmaceutical compositions containing them
IL89502A0 (en) Plantinum derivatives and pharmaceutical compositions containing the same
IL96747A0 (en) Oxazole derivatives and pharmaceutical compositions containing them
IL90065A0 (en) 1alpha-hydroxyvitamin-d homologs and pharmaceutical compositions containing them
NZ225613A (en) Benzazepin-2-one derivatives and pharmaceutical compositions
IL95994A0 (en) Carbamate esters and pharmaceutical compositions containing them
IL92650A0 (en) Polyhydroxybenzyloxypropanolamides and pharmaceutical compositions containing them
IL89286A0 (en) Quinolone compounds and pharmaceutical compositions containing them
IL89049A0 (en) Pharmaceutical composition containing 4-aroylimidazol-2-ones
NZ228281A (en) Tricyclo-amine derivatives and pharmaceutical compositions
IL78707A (en) Rioprostil-polyvinyl-pyrrolidone complex and pharmaceutical compositions containing it
IL85524A0 (en) Heterocyclyl-2-propyn-1-amines and pharmaceutical compositions containing same